Low-dose intravenous pamidronate treatment in osteogenesis imperfecta
Different therapy models have been tried in order to decrease bone resorption in osteogenesis imperfecta. Bisphosphonates are a group of drugs that mainly suppress osteoclast-mediated bone resorption, thus reducing bone turnover. We assessed the effects of low-dose bisphosphonate treatment in...
Saved in:
| Main Authors: | Damla Gökşen, Mahmut Coker, Sükran Darcan, Timur Köse, Sinan Kara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2006-04-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/2612 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
by: Hsiang-Yu Lin, et al.
Published: (2008-10-01) -
Persistent elevated serum levels of intact parathyroid hormone after reoperation for primary hyperparathyroidism and after pamidronate therapy
by: Sükran Darcan, et al.
Published: (2003-07-01) -
The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta
by: Pelin Adiyaman, et al.
Published: (2004-10-01) -
Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta
by: Chia-Hsuan Lin, et al.
Published: (2014-08-01) -
Usefulness of the myocardial performance index (MPI) for assessing ventricular function in obese pediatric patients
by: Ertürk Levent, et al.
Published: (2005-01-01)